AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer.

Zhang K, Liu P, Tang H, Xie X, Kong Y, Song C, Qiu X, Xiao X

Open source

DOI
10.3389/fphar.2018.01248
Published
2018
Container
Frontiers in pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 4/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2018.01248,
  title = {AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer.},
  author = {Zhang K and Liu P and Tang H and Xie X and Kong Y and Song C and Qiu X and Xiao X},
  year = {2018},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2018.01248},
  url = {https://doi.org/10.3389/fphar.2018.01248}
}

RIS

TY  - JOUR
TI  - AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer.
AU  - Zhang K
AU  - Liu P
AU  - Tang H
AU  - Xie X
AU  - Kong Y
AU  - Song C
AU  - Qiu X
AU  - Xiao X
PY  - 2018
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2018.01248
UR  - https://doi.org/10.3389/fphar.2018.01248
ER  - 

APA

K, Z., P, L., H, T., X, X., Y, K., C, S., X, Q., & X, X. (2018). AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2018.01248

Source records